Mechanisms of Regional Fat Loss in Humans

Overview

About this study

The purpose of this study is determine the physiological/cellular mechanisms that allow for preferential loss of fat from different depots and to to link region-specific fat loss with relevant metabolic responses.  Also to determine whether pre- and postmenopausal women have different regional fat loss and whether those patterns differ from those seen in men. 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Males and females 18-70 years who are able to comprehend instructions, follow study procedures and who willing to provide written, informed consent will be included.
  • Overweight/Obese volunteers will have a BMI 29.0 – 37.0 kg/m2
  • Female subjects are eligible if they meet the following criteria:
    • Are not pregnant or nursing.
    • All women of childbearing potential will have a negative urine pregnancy test at screening and a negative urine pregnancy test day of admission for inpatient study visit.
    • Post Menopausal will be defined as I

Exclusion Criteria:

  • Individuals with a history of a disease process such as:
    • Ischemic heart disease
    • Atherosclerotic valvular disease
    • Persistent blood pressure greater than 160/95 despite antihypertensive medication
  • Smokers
  • Diagnosis Diabetes Mellitus
  • Concomitant use of medications that can alter free fatty acid metabolism, including, but not limited to niacin, thiazolidinediones, beta-blockers, oral or injected corticosteroids or anabolic steroids.
  • Allergy to lidocaine

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 11/19/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Michael Jensen, M.D.

Contact us for the latest status

Contact information:

Madeline Reid

(507) 255-6062

reid.madeline@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20595154

Mayo Clinic Footer